government and the two leading GLP-1 drugmakers, Eli Lilly and Novo Nordisk, to reduce the costs of these drugs
Can I get Ozempic or Trulicity for weight loss
Conversely, point estimates for tirzepatide showed a potential modest advantage for heart failure endpoints, with CIs compatible with no difference, consistent with recent data supporting protective effects of semaglutide and tirzepatide on heart failure outcomes and a potential incremental benefit with the latter 22
A majority of the reported events occurred in patients who had experienced nausea, vomiting, or diarrhea, leading to volume depletion [see Adverse Reactions (6)]
Brand-Specific Considerations: Mounjaro and Zepbound Tirzepatide is a dual GIP/GLP-1 receptor agonist marketed as Mounjaro for type 2 diabetes and Zepbound for weight management
Oral Semaglutide is a compounded medication that contains Semaglutide, a synthetic version of the naturally occurring hormone GLP-1 (glucagon-like peptide-1)